SlideShare a Scribd company logo
1 of 34
Journal Scan
Presenter
Praveen gupta
Moderator
Dr Raja selvaraj
Department of cardiology
JIPMER
Pondicherry
India
03.07.2017
1
2
Introduction
3
 Catheter ablation standard therapy for AF
 Recurrence after pulmonary vein isolation (PVI) is electrical reconnection between PV) and the left atrium
(LA).
 Presence of non-PV foci (NPVF) is related to AF recurrence after multiple PVI procedures, as well as to
very late AF recurrence
 Impact of NPVF on AF recurrence has not evaluated
 Present study used examine NPVF prevalence in the first and second PVI sessions and evaluate the impact
of NPVF on AF recurrence after catheter ablation for LA-PV reconnection
Methods
4
 Retrospectively analyzed
 284 patients with drug-refractory paroxysmal atrial fibrillation (PAF) (232) or persistent
atrial fibrillation (PeAF) (52), who underwent PVI between February 2010 and February
2014 at the Tokyo Metropolitan Hiroo Hospital
 Patients were excluded,
 PeAF lasting >1 year (61)
 Short interval between the first and second procedures ( 2)
 Use of amiodarone during the procedure (3 patients)
 Followup <1 year
Methods
5
 A total of 216 patients (172 with PAF and 44 with PeAF lasting <1 year) were included
(76%)
 All patients underwent a second electrophysiological study at the 6-month follow-up after the
first procedure, regardless of AF recurrence
 Performed PVI and catheter ablation for NPVF in the first and second sessions.
 NPVF detected for the first time in the second session were defined as newly developed
NPVF (new-NPVF)
 Each patient to either the new-NPVF(+) or new-NPVF(-) group, depending on whether
they developed NPVF between the first and second session
Methods
6
Result
7
8
Result
9
Result
10
Result
Discussion
11
 Prevalence of NPVF higher in the second session than in the first
 New-NPVF in the second session correlated to AF recurrence after repeated catheter ablation
 AF history and AF recurrence after the first session were predictors for patients likely to
develop new-NPVF
 Proportion with NPVF was 9.6% in the first session
 Proportion with NPVF in second session was lower than in previous reports
 Among the patients with AF recurrence after the first session, 19 (33.9%) had new-NPVF,
indicating increased prevalence of NPVF as a trigger for recurrent AF after PVI
 NPVF originating from the interatrial septum in 22%
Discussion
12
 OUTCOME AFTER THE SECOND SESSION
 NPVF important risk factor for AF recurrence after second session in patients with PAF
 Patients without AF recurrence 6 months after the first session had new-NPVF and AF recurrences after
the second procedure
 These patients are prone to develop late recurrence after PVI
 Ablation for new-NPVF highly recommended to avoid future recurrences
 NPVF in the LA area had a higher recurrence than with NPVF in the SVC or crista terminalis
 Patients who show new-NPVF, long follow-up with additional medication needed
Discussion
13
 PREDICTORS FOR NEW-NPVF.
 AF history
 NPVF in the first session
 Longer AF duration
 AF type was not related to new-NPVF
 Sex and LA volume were not predictors for new-NPVF
Discussion
14
 AF TRIGGERS AND ORIGIN
 Patients without AF recurrence after the first session had high PV reconnection rate (68.2%,
107 of 157)
 New-NPVF independent predictor for AF recurrence after the second session, even when
these foci were ablated. .
Study limitations
15
 Single-center
 Retrospective study.
 Follow-up period was short (230 days)
 Proportion of patientswith NPVF might be underestimated; indeed, NPVF
 Occurrence was lower than that reported in previous studies.
 Some patients had AF recurrence due to LA-PV reconnection even after the second session
 We did not target NPVF that did not induce AF, which influenced our results
 Electrocardiography and 24-h Holter electrocardiographic monitoring every 3 to 6 months after the
procedure is insufficient to detect AF episodes in patients with asymptomatic AFrecurrence
Conclusions
16
 Higher number of NPVF were detected in the second session of PVI
 Distribution of NPVF location and number were also different than during the first session
 Occurrence of NPVF developed after the first PVI session was correlated with AF recurrence
after catheter ablation of LA-PV reconnection
 Long AF history and AF recurrence after the first session need additional ablation for NPVF
 AF triggers, with long-term follow-up
 NPVF detection and ablation may represent important therapeutic options to prevent AF
recurrence, especially in patients who require repeated procedures.
17
18
Introduction
19
 HRV capture intervals between consecutive normal heart beats
 Reflect cardiac autonomic function
 Abnormal HRV independent predictor of sudden cardiac death in CHF
 PVCs from 24-h Holter associated with development of heart failure
 We hypothesized that abnormal HRV identify participants who are at an increased risk for the
development of CHF
Method
20
 Noninstitutionalized individuals 65 years of age or older
 5,201 participants, recruited from 1989 to 1990.
 687 African-American individuals were recruited from 1992 to 1993
 Physical examinations, laboratory tests, and questionnaires obtained
 Holter recording done at year 2 of the CHS, whereas the African-American had baseline
assessments at year 5, had Holter recordings performed in year 7
Exclusion criteria
21
 Participants with unusable Holter data (i.e., paced rhythms, atrial fibrillation, wandering
atrial pacemaker, or >20% ectopic beats)
 Heart failure at time of Holter monitoring
 Those with unknown baseline heart failure status
 Patient with missing components of Health ABC score
 Participants excluded due to incomplete follow-up data.
Outcomes
22
 Primary outcome-Incident CHF
 Heart failure, MI, and stroke tabulated through regular surveys, clinic visits, and calls
 Participants were able to report any changes in their medical care
 Incident events explored through medical records including discharge summaries, hospital
face sheets, or using International Classification of Diseases-Ninth
Ambulatory ECG monitoring and assessment of HRV
23
 Holter tapes were recorded
 Holter analyses were reviewed by an investigator
 Only beats with uniformly detected onsets were labeled as normal
 The longest and shortest true N–N intervals were identified
 Time domain, frequency domain, and nonlinear HRV measures were determined
 Heart rate turbulence (HRT), a relatively novel measure of heart rate responses to isolated
PVCs, was also calculated
 HRT is generally reported as the categorical variables turbulence onset (TO) and turbulence
slope (TS)
 TS 3.0 ms/RR was categorized as normal, whereas TO 0% considered normal
Results
24
 260 participants (19%) developed CHF during follow-up (median 10.5 years)
 CHF patient were more likely male, older, and higher body mass index.
 CHF patient have higher baseline heart rate and systolic blood pressure, as well as higher
baseline NT-proBNP, creatinine, and fasting glucose levels
 More likely to have left ventricular hypertrophy and CAD
 Participants who developed CHF had decreased 24-h HRV and circadian HRV
 Significant differences seen in very low frequency (VLF) power
Results
25
 Participants who developed CHF, nonlinear HRV measures that capture the organization of
the heart rate time series were significantly more abnormal, reflecting greater disorganization
in heart rate control
 Abnormal HRT slope and onset more prevalent in those developed CHF
 Ventricular and atrial ectopy counts significantly higher in the CHF group
 24-h mean heart rate not different between with and without incident CHF
Subgroup analysis
26
 A comparison of Holter-based parameters in the subset of participants with a baseline NT-
proBNP 190 pg/ml (1,000), who did (142, 14.2%) and did not (858, 85.8%) develop CHF can
be seen
 Participants who developed CHF in this subcohort had significantly higher Health ABC
scores
Discussion
27
 Increased ventricular ectopy counts and abnormal HRV measures from 24-h Holter
recordings, including decreased DFA1, decreased CV%, increased ln VLF, and abnormal
HRT onset, added to the predictive power of the Health ABC score to identify asymptomatic
older adults who are at increased risk of developing CHF
 The model C-statistic increased from 0.73 to 0.77 when HRV was included.
 Low-risk subcohort, as defined by NT-proBNP #190 pg/ml, the Health ABC components
significantly associated with CHF were unchanged, and decreased DFA1 remained
independently associated with incident CHF
Result
28
 HRV parameters were associated with incident CHF independent of the Health ABC score components
 Older adults who have cardiac autonomic dysfunction, as manifested by abnormal HRV, may be
predisposed to the development of CHF
 DFA1, first described by Peng et al, measures the randomness of the N-N intervals (i.e., the intervals
between normal heart beats in a time series
 Lower value of DFA1 reflect a more disorganized, less predictable sinus rhythm
 Lower DFA1 was associated with increased mortality in patients with reduced ejection fraction after MI
Result
29
 Decreased DFA1 with increased heart failure hospitalizations
 Decreased DFA1 a strong risk factor for cardiovascular death
 Relationship between DFA1 and incident CHF in asymptomatic older adults
 Study confirmed that an increased number of PVCs was associated with an increased risk of
CHF, independent of the Health ABC score components,
Study limitations
30
 HRV can only be measured in normal sinus rhythm, which exclude those with atrial
fibrillation, wandering atrial pacemaker, excessive ectopy, or an underlying paced rhythm,
excluding individuals who are at the greatest risk of developing CHF
 Health ABC score components were obtained 2 years before the Holter recordings in the
African-American cohort, these participants may have had a different Health ABC score at
the time of their 24-h Holter measurements
Study limitations
31
 we did not correct for multiple comparisons, thereby increasing the risk of type I error.
 Full clinical application of these findings would require that 24-h Holter recordings be
analyzed to research standards
Conclusions
32
 Abnormal HRV significantly and independently associated with incident CHF
 When combined with increased PVCs, improved the predictive power of the Health ABC
score
 Among low-risk older adults with NTproBNP 190 pg/ml, HRV added to the clinical risk
model.
 Identification of asymptomatic older adults with abnormal HRV could potentially help direct
targeted strategies for the primary prevention of heart failure
Take home message
33
 NPVF detection and ablation may represent important therapeutic options to prevent AF
recurrence, especially in patients who require repeated procedures
 Abnormal HRV significantly and independently associated with incident CHF
34
Thank You

More Related Content

What's hot

Management of Atrial Fibrillation Science:Myths & Fashion
Management of Atrial Fibrillation Science:Myths & FashionManagement of Atrial Fibrillation Science:Myths & Fashion
Management of Atrial Fibrillation Science:Myths & Fashiontheheartofthematter
 
Practical application of anticoagulation therapy af and vte april 12
Practical application of  anticoagulation therapy af and vte april 12Practical application of  anticoagulation therapy af and vte april 12
Practical application of anticoagulation therapy af and vte april 12Ihsaan Peer
 
Stroke prevention in patients with atrial fibrillation
Stroke prevention in patients with atrial fibrillationStroke prevention in patients with atrial fibrillation
Stroke prevention in patients with atrial fibrillationMgfamiliar Net
 
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...Boehringer Ingelheim Pharmaceuticals, Inc.
 
Management of HOCM
Management of HOCMManagement of HOCM
Management of HOCMRohitWalse2
 
96091164 Slice Ct And Cerebral Atherosclerosis02
96091164 Slice Ct And Cerebral Atherosclerosis0296091164 Slice Ct And Cerebral Atherosclerosis02
96091164 Slice Ct And Cerebral Atherosclerosis02calaf0618
 
Heart Failure Preserved EF
Heart Failure Preserved EF Heart Failure Preserved EF
Heart Failure Preserved EF Han Naung Tun
 
Newer Oral Anticoagulants or warfarin in DVT/PE
Newer Oral Anticoagulants or warfarin in DVT/PENewer Oral Anticoagulants or warfarin in DVT/PE
Newer Oral Anticoagulants or warfarin in DVT/PESatyam Rajvanshi
 
Heart Transplantation in India, Delhi
Heart Transplantation in India, DelhiHeart Transplantation in India, Delhi
Heart Transplantation in India, DelhiDr. Kewal Krishan
 
Acute Decompensated Heart Failure
Acute Decompensated Heart FailureAcute Decompensated Heart Failure
Acute Decompensated Heart Failuredrucsamal
 
Important Clinical Trials In Cardiology - An Overview 2016-17
Important Clinical Trials In Cardiology - An Overview 2016-17Important Clinical Trials In Cardiology - An Overview 2016-17
Important Clinical Trials In Cardiology - An Overview 2016-17Amit Verma
 
STEMI Late Presentation - Management and practical approach
STEMI Late Presentation - Management and practical approachSTEMI Late Presentation - Management and practical approach
STEMI Late Presentation - Management and practical approachSatyam Rajvanshi
 

What's hot (20)

Management of Atrial Fibrillation Science:Myths & Fashion
Management of Atrial Fibrillation Science:Myths & FashionManagement of Atrial Fibrillation Science:Myths & Fashion
Management of Atrial Fibrillation Science:Myths & Fashion
 
Practical application of anticoagulation therapy af and vte april 12
Practical application of  anticoagulation therapy af and vte april 12Practical application of  anticoagulation therapy af and vte april 12
Practical application of anticoagulation therapy af and vte april 12
 
Devices
DevicesDevices
Devices
 
Stroke prevention in patients with atrial fibrillation
Stroke prevention in patients with atrial fibrillationStroke prevention in patients with atrial fibrillation
Stroke prevention in patients with atrial fibrillation
 
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
 
Management of HOCM
Management of HOCMManagement of HOCM
Management of HOCM
 
Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Conco...
Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Conco...Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Conco...
Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Conco...
 
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
 
96091164 Slice Ct And Cerebral Atherosclerosis02
96091164 Slice Ct And Cerebral Atherosclerosis0296091164 Slice Ct And Cerebral Atherosclerosis02
96091164 Slice Ct And Cerebral Atherosclerosis02
 
BIOMARKERS IN ACS
BIOMARKERS IN ACSBIOMARKERS IN ACS
BIOMARKERS IN ACS
 
Heart Failure Preserved EF
Heart Failure Preserved EF Heart Failure Preserved EF
Heart Failure Preserved EF
 
Electric Storm
Electric StormElectric Storm
Electric Storm
 
Arizona Af Albers
Arizona Af AlbersArizona Af Albers
Arizona Af Albers
 
Newer Oral Anticoagulants or warfarin in DVT/PE
Newer Oral Anticoagulants or warfarin in DVT/PENewer Oral Anticoagulants or warfarin in DVT/PE
Newer Oral Anticoagulants or warfarin in DVT/PE
 
Rob fib
Rob fibRob fib
Rob fib
 
Heart Transplantation in India, Delhi
Heart Transplantation in India, DelhiHeart Transplantation in India, Delhi
Heart Transplantation in India, Delhi
 
Acute Decompensated Heart Failure
Acute Decompensated Heart FailureAcute Decompensated Heart Failure
Acute Decompensated Heart Failure
 
Device Therapy in Heart Failure
Device Therapy in Heart FailureDevice Therapy in Heart Failure
Device Therapy in Heart Failure
 
Important Clinical Trials In Cardiology - An Overview 2016-17
Important Clinical Trials In Cardiology - An Overview 2016-17Important Clinical Trials In Cardiology - An Overview 2016-17
Important Clinical Trials In Cardiology - An Overview 2016-17
 
STEMI Late Presentation - Management and practical approach
STEMI Late Presentation - Management and practical approachSTEMI Late Presentation - Management and practical approach
STEMI Late Presentation - Management and practical approach
 

Similar to Cardiology Journal scan

Predictors of Outcome in Acute Respiratory Distress Syndrome with Acute febri...
Predictors of Outcome in Acute Respiratory Distress Syndrome with Acute febri...Predictors of Outcome in Acute Respiratory Distress Syndrome with Acute febri...
Predictors of Outcome in Acute Respiratory Distress Syndrome with Acute febri...DrTapasTripathi
 
2010 heart failure_guideline_sec_12
2010 heart failure_guideline_sec_122010 heart failure_guideline_sec_12
2010 heart failure_guideline_sec_12drucsamal
 
Managing Ventricular Arrhythmia In First In Man Studies A Nada
Managing Ventricular Arrhythmia In First In Man Studies A NadaManaging Ventricular Arrhythmia In First In Man Studies A Nada
Managing Ventricular Arrhythmia In First In Man Studies A Nadaadelnada
 
Warfarin related nephropathy; Evidence Based Medicine
Warfarin related nephropathy; Evidence Based MedicineWarfarin related nephropathy; Evidence Based Medicine
Warfarin related nephropathy; Evidence Based MedicineWisit Cheungpasitporn
 
A fib treatment strategies
A fib treatment strategiesA fib treatment strategies
A fib treatment strategiesfaminteractive
 
Current Modalities for Invasive and Non Invasive Monitoring of Volume status ...
Current Modalities for Invasive and Non Invasive Monitoring of Volume status ...Current Modalities for Invasive and Non Invasive Monitoring of Volume status ...
Current Modalities for Invasive and Non Invasive Monitoring of Volume status ...drucsamal
 
Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalizationAnna Wu
 
How Early ARNI is Early.pptx
How Early ARNI is Early.pptxHow Early ARNI is Early.pptx
How Early ARNI is Early.pptxPuneetGupta542512
 
Effect of_continuous_positive_airway_pressure_(cpap)_and_non-invasive_positi...
 Effect of_continuous_positive_airway_pressure_(cpap)_and_non-invasive_positi... Effect of_continuous_positive_airway_pressure_(cpap)_and_non-invasive_positi...
Effect of_continuous_positive_airway_pressure_(cpap)_and_non-invasive_positi...Muhammad Badawi
 
How Early ARNI is Early.pptx
How Early ARNI is Early.pptxHow Early ARNI is Early.pptx
How Early ARNI is Early.pptxPuneetGupta542512
 
Catheterisation study and operability assessment
Catheterisation study and operability assessmentCatheterisation study and operability assessment
Catheterisation study and operability assessmentIndia CTVS
 
Primary pulmonary hypertension
Primary pulmonary hypertensionPrimary pulmonary hypertension
Primary pulmonary hypertensionSachin Sondhi
 
The patient with AHF on the ICU : Respiratory Support
The patient with AHF on the ICU : Respiratory SupportThe patient with AHF on the ICU : Respiratory Support
The patient with AHF on the ICU : Respiratory Supportdrucsamal
 
Patent foramen ovale management in cryptogenic stroke
Patent foramen ovale management in cryptogenic strokePatent foramen ovale management in cryptogenic stroke
Patent foramen ovale management in cryptogenic strokePrisma Health Upstate
 
2015年3月刊:TAVR专栏
2015年3月刊:TAVR专栏2015年3月刊:TAVR专栏
2015年3月刊:TAVR专栏Rahab Jin
 
Pesit trial New England Journal of Medicine
Pesit trial New England Journal of MedicinePesit trial New England Journal of Medicine
Pesit trial New England Journal of MedicineDr fakhir Raza
 

Similar to Cardiology Journal scan (20)

FLAVOUR TRIAL
FLAVOUR TRIALFLAVOUR TRIAL
FLAVOUR TRIAL
 
Predictors of Outcome in Acute Respiratory Distress Syndrome with Acute febri...
Predictors of Outcome in Acute Respiratory Distress Syndrome with Acute febri...Predictors of Outcome in Acute Respiratory Distress Syndrome with Acute febri...
Predictors of Outcome in Acute Respiratory Distress Syndrome with Acute febri...
 
Right ventricular pacing revisited
Right ventricular pacing revisitedRight ventricular pacing revisited
Right ventricular pacing revisited
 
2010 heart failure_guideline_sec_12
2010 heart failure_guideline_sec_122010 heart failure_guideline_sec_12
2010 heart failure_guideline_sec_12
 
Journal club af
Journal club afJournal club af
Journal club af
 
Managing Ventricular Arrhythmia In First In Man Studies A Nada
Managing Ventricular Arrhythmia In First In Man Studies A NadaManaging Ventricular Arrhythmia In First In Man Studies A Nada
Managing Ventricular Arrhythmia In First In Man Studies A Nada
 
Warfarin related nephropathy; Evidence Based Medicine
Warfarin related nephropathy; Evidence Based MedicineWarfarin related nephropathy; Evidence Based Medicine
Warfarin related nephropathy; Evidence Based Medicine
 
My presentation
My presentationMy presentation
My presentation
 
A fib treatment strategies
A fib treatment strategiesA fib treatment strategies
A fib treatment strategies
 
Current Modalities for Invasive and Non Invasive Monitoring of Volume status ...
Current Modalities for Invasive and Non Invasive Monitoring of Volume status ...Current Modalities for Invasive and Non Invasive Monitoring of Volume status ...
Current Modalities for Invasive and Non Invasive Monitoring of Volume status ...
 
Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalization
 
How Early ARNI is Early.pptx
How Early ARNI is Early.pptxHow Early ARNI is Early.pptx
How Early ARNI is Early.pptx
 
Effect of_continuous_positive_airway_pressure_(cpap)_and_non-invasive_positi...
 Effect of_continuous_positive_airway_pressure_(cpap)_and_non-invasive_positi... Effect of_continuous_positive_airway_pressure_(cpap)_and_non-invasive_positi...
Effect of_continuous_positive_airway_pressure_(cpap)_and_non-invasive_positi...
 
How Early ARNI is Early.pptx
How Early ARNI is Early.pptxHow Early ARNI is Early.pptx
How Early ARNI is Early.pptx
 
Catheterisation study and operability assessment
Catheterisation study and operability assessmentCatheterisation study and operability assessment
Catheterisation study and operability assessment
 
Primary pulmonary hypertension
Primary pulmonary hypertensionPrimary pulmonary hypertension
Primary pulmonary hypertension
 
The patient with AHF on the ICU : Respiratory Support
The patient with AHF on the ICU : Respiratory SupportThe patient with AHF on the ICU : Respiratory Support
The patient with AHF on the ICU : Respiratory Support
 
Patent foramen ovale management in cryptogenic stroke
Patent foramen ovale management in cryptogenic strokePatent foramen ovale management in cryptogenic stroke
Patent foramen ovale management in cryptogenic stroke
 
2015年3月刊:TAVR专栏
2015年3月刊:TAVR专栏2015年3月刊:TAVR专栏
2015年3月刊:TAVR专栏
 
Pesit trial New England Journal of Medicine
Pesit trial New England Journal of MedicinePesit trial New England Journal of Medicine
Pesit trial New England Journal of Medicine
 

More from PRAVEEN GUPTA

Praveen's Indian cardiology board review and self-assessment
Praveen's Indian cardiology board review and self-assessmentPraveen's Indian cardiology board review and self-assessment
Praveen's Indian cardiology board review and self-assessmentPRAVEEN GUPTA
 
Evaluation and management of Pacemaker malfunction
Evaluation and management of Pacemaker malfunctionEvaluation and management of Pacemaker malfunction
Evaluation and management of Pacemaker malfunctionPRAVEEN GUPTA
 
Air pollution and cardiovascular disease
Air pollution and cardiovascular diseaseAir pollution and cardiovascular disease
Air pollution and cardiovascular diseasePRAVEEN GUPTA
 
Chronic thromboembolic pulmonary hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH)Chronic thromboembolic pulmonary hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH)PRAVEEN GUPTA
 
ICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathyICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathyPRAVEEN GUPTA
 
2015 Jones criteria for the diagnosis of rheumatic fever
2015 Jones criteria for the diagnosis of rheumatic fever2015 Jones criteria for the diagnosis of rheumatic fever
2015 Jones criteria for the diagnosis of rheumatic feverPRAVEEN GUPTA
 
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillationPulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillationPRAVEEN GUPTA
 
Hybrid atrial fibrillation ablation
Hybrid atrial fibrillation ablationHybrid atrial fibrillation ablation
Hybrid atrial fibrillation ablationPRAVEEN GUPTA
 
Cardiology Journal club
Cardiology Journal clubCardiology Journal club
Cardiology Journal clubPRAVEEN GUPTA
 
Cardiovascular complication of cancer chemotherapy
Cardiovascular complication of cancer chemotherapyCardiovascular complication of cancer chemotherapy
Cardiovascular complication of cancer chemotherapyPRAVEEN GUPTA
 
Wearable defibrillator
Wearable defibrillatorWearable defibrillator
Wearable defibrillatorPRAVEEN GUPTA
 
Diabetic cardiomyopathy (Pathophysiology)
Diabetic cardiomyopathy (Pathophysiology)Diabetic cardiomyopathy (Pathophysiology)
Diabetic cardiomyopathy (Pathophysiology)PRAVEEN GUPTA
 
Chest xray for evaluation of cardiovascular system
Chest xray for evaluation of cardiovascular systemChest xray for evaluation of cardiovascular system
Chest xray for evaluation of cardiovascular systemPRAVEEN GUPTA
 

More from PRAVEEN GUPTA (20)

Praveen's Indian cardiology board review and self-assessment
Praveen's Indian cardiology board review and self-assessmentPraveen's Indian cardiology board review and self-assessment
Praveen's Indian cardiology board review and self-assessment
 
Evaluation and management of Pacemaker malfunction
Evaluation and management of Pacemaker malfunctionEvaluation and management of Pacemaker malfunction
Evaluation and management of Pacemaker malfunction
 
Air pollution and cardiovascular disease
Air pollution and cardiovascular diseaseAir pollution and cardiovascular disease
Air pollution and cardiovascular disease
 
Chronic thromboembolic pulmonary hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH)Chronic thromboembolic pulmonary hypertension (CTEPH)
Chronic thromboembolic pulmonary hypertension (CTEPH)
 
ICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathyICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathy
 
2015 Jones criteria for the diagnosis of rheumatic fever
2015 Jones criteria for the diagnosis of rheumatic fever2015 Jones criteria for the diagnosis of rheumatic fever
2015 Jones criteria for the diagnosis of rheumatic fever
 
Cardiology mcq
Cardiology mcq Cardiology mcq
Cardiology mcq
 
Heart block
Heart blockHeart block
Heart block
 
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillationPulseless electrical activity, Ventricular flutter, Ventricular fibrillation
Pulseless electrical activity, Ventricular flutter, Ventricular fibrillation
 
Kawasaki diseases
Kawasaki diseasesKawasaki diseases
Kawasaki diseases
 
Hybrid atrial fibrillation ablation
Hybrid atrial fibrillation ablationHybrid atrial fibrillation ablation
Hybrid atrial fibrillation ablation
 
Cardiology Journal club
Cardiology Journal clubCardiology Journal club
Cardiology Journal club
 
AICD programming
AICD programmingAICD programming
AICD programming
 
Cardiovascular complication of cancer chemotherapy
Cardiovascular complication of cancer chemotherapyCardiovascular complication of cancer chemotherapy
Cardiovascular complication of cancer chemotherapy
 
Wearable defibrillator
Wearable defibrillatorWearable defibrillator
Wearable defibrillator
 
Diabetic cardiomyopathy (Pathophysiology)
Diabetic cardiomyopathy (Pathophysiology)Diabetic cardiomyopathy (Pathophysiology)
Diabetic cardiomyopathy (Pathophysiology)
 
Heart sounds
Heart soundsHeart sounds
Heart sounds
 
ECG/X-ray Quiz
ECG/X-ray QuizECG/X-ray Quiz
ECG/X-ray Quiz
 
Pericardiocentesis
PericardiocentesisPericardiocentesis
Pericardiocentesis
 
Chest xray for evaluation of cardiovascular system
Chest xray for evaluation of cardiovascular systemChest xray for evaluation of cardiovascular system
Chest xray for evaluation of cardiovascular system
 

Recently uploaded

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Science lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonScience lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonJericReyAuditor
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 

Recently uploaded (20)

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Science lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonScience lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lesson
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 

Cardiology Journal scan

  • 1. Journal Scan Presenter Praveen gupta Moderator Dr Raja selvaraj Department of cardiology JIPMER Pondicherry India 03.07.2017 1
  • 2. 2
  • 3. Introduction 3  Catheter ablation standard therapy for AF  Recurrence after pulmonary vein isolation (PVI) is electrical reconnection between PV) and the left atrium (LA).  Presence of non-PV foci (NPVF) is related to AF recurrence after multiple PVI procedures, as well as to very late AF recurrence  Impact of NPVF on AF recurrence has not evaluated  Present study used examine NPVF prevalence in the first and second PVI sessions and evaluate the impact of NPVF on AF recurrence after catheter ablation for LA-PV reconnection
  • 4. Methods 4  Retrospectively analyzed  284 patients with drug-refractory paroxysmal atrial fibrillation (PAF) (232) or persistent atrial fibrillation (PeAF) (52), who underwent PVI between February 2010 and February 2014 at the Tokyo Metropolitan Hiroo Hospital  Patients were excluded,  PeAF lasting >1 year (61)  Short interval between the first and second procedures ( 2)  Use of amiodarone during the procedure (3 patients)  Followup <1 year
  • 5. Methods 5  A total of 216 patients (172 with PAF and 44 with PeAF lasting <1 year) were included (76%)  All patients underwent a second electrophysiological study at the 6-month follow-up after the first procedure, regardless of AF recurrence  Performed PVI and catheter ablation for NPVF in the first and second sessions.  NPVF detected for the first time in the second session were defined as newly developed NPVF (new-NPVF)  Each patient to either the new-NPVF(+) or new-NPVF(-) group, depending on whether they developed NPVF between the first and second session
  • 11. Discussion 11  Prevalence of NPVF higher in the second session than in the first  New-NPVF in the second session correlated to AF recurrence after repeated catheter ablation  AF history and AF recurrence after the first session were predictors for patients likely to develop new-NPVF  Proportion with NPVF was 9.6% in the first session  Proportion with NPVF in second session was lower than in previous reports  Among the patients with AF recurrence after the first session, 19 (33.9%) had new-NPVF, indicating increased prevalence of NPVF as a trigger for recurrent AF after PVI  NPVF originating from the interatrial septum in 22%
  • 12. Discussion 12  OUTCOME AFTER THE SECOND SESSION  NPVF important risk factor for AF recurrence after second session in patients with PAF  Patients without AF recurrence 6 months after the first session had new-NPVF and AF recurrences after the second procedure  These patients are prone to develop late recurrence after PVI  Ablation for new-NPVF highly recommended to avoid future recurrences  NPVF in the LA area had a higher recurrence than with NPVF in the SVC or crista terminalis  Patients who show new-NPVF, long follow-up with additional medication needed
  • 13. Discussion 13  PREDICTORS FOR NEW-NPVF.  AF history  NPVF in the first session  Longer AF duration  AF type was not related to new-NPVF  Sex and LA volume were not predictors for new-NPVF
  • 14. Discussion 14  AF TRIGGERS AND ORIGIN  Patients without AF recurrence after the first session had high PV reconnection rate (68.2%, 107 of 157)  New-NPVF independent predictor for AF recurrence after the second session, even when these foci were ablated. .
  • 15. Study limitations 15  Single-center  Retrospective study.  Follow-up period was short (230 days)  Proportion of patientswith NPVF might be underestimated; indeed, NPVF  Occurrence was lower than that reported in previous studies.  Some patients had AF recurrence due to LA-PV reconnection even after the second session  We did not target NPVF that did not induce AF, which influenced our results  Electrocardiography and 24-h Holter electrocardiographic monitoring every 3 to 6 months after the procedure is insufficient to detect AF episodes in patients with asymptomatic AFrecurrence
  • 16. Conclusions 16  Higher number of NPVF were detected in the second session of PVI  Distribution of NPVF location and number were also different than during the first session  Occurrence of NPVF developed after the first PVI session was correlated with AF recurrence after catheter ablation of LA-PV reconnection  Long AF history and AF recurrence after the first session need additional ablation for NPVF  AF triggers, with long-term follow-up  NPVF detection and ablation may represent important therapeutic options to prevent AF recurrence, especially in patients who require repeated procedures.
  • 17. 17
  • 18. 18
  • 19. Introduction 19  HRV capture intervals between consecutive normal heart beats  Reflect cardiac autonomic function  Abnormal HRV independent predictor of sudden cardiac death in CHF  PVCs from 24-h Holter associated with development of heart failure  We hypothesized that abnormal HRV identify participants who are at an increased risk for the development of CHF
  • 20. Method 20  Noninstitutionalized individuals 65 years of age or older  5,201 participants, recruited from 1989 to 1990.  687 African-American individuals were recruited from 1992 to 1993  Physical examinations, laboratory tests, and questionnaires obtained  Holter recording done at year 2 of the CHS, whereas the African-American had baseline assessments at year 5, had Holter recordings performed in year 7
  • 21. Exclusion criteria 21  Participants with unusable Holter data (i.e., paced rhythms, atrial fibrillation, wandering atrial pacemaker, or >20% ectopic beats)  Heart failure at time of Holter monitoring  Those with unknown baseline heart failure status  Patient with missing components of Health ABC score  Participants excluded due to incomplete follow-up data.
  • 22. Outcomes 22  Primary outcome-Incident CHF  Heart failure, MI, and stroke tabulated through regular surveys, clinic visits, and calls  Participants were able to report any changes in their medical care  Incident events explored through medical records including discharge summaries, hospital face sheets, or using International Classification of Diseases-Ninth
  • 23. Ambulatory ECG monitoring and assessment of HRV 23  Holter tapes were recorded  Holter analyses were reviewed by an investigator  Only beats with uniformly detected onsets were labeled as normal  The longest and shortest true N–N intervals were identified  Time domain, frequency domain, and nonlinear HRV measures were determined  Heart rate turbulence (HRT), a relatively novel measure of heart rate responses to isolated PVCs, was also calculated  HRT is generally reported as the categorical variables turbulence onset (TO) and turbulence slope (TS)  TS 3.0 ms/RR was categorized as normal, whereas TO 0% considered normal
  • 24. Results 24  260 participants (19%) developed CHF during follow-up (median 10.5 years)  CHF patient were more likely male, older, and higher body mass index.  CHF patient have higher baseline heart rate and systolic blood pressure, as well as higher baseline NT-proBNP, creatinine, and fasting glucose levels  More likely to have left ventricular hypertrophy and CAD  Participants who developed CHF had decreased 24-h HRV and circadian HRV  Significant differences seen in very low frequency (VLF) power
  • 25. Results 25  Participants who developed CHF, nonlinear HRV measures that capture the organization of the heart rate time series were significantly more abnormal, reflecting greater disorganization in heart rate control  Abnormal HRT slope and onset more prevalent in those developed CHF  Ventricular and atrial ectopy counts significantly higher in the CHF group  24-h mean heart rate not different between with and without incident CHF
  • 26. Subgroup analysis 26  A comparison of Holter-based parameters in the subset of participants with a baseline NT- proBNP 190 pg/ml (1,000), who did (142, 14.2%) and did not (858, 85.8%) develop CHF can be seen  Participants who developed CHF in this subcohort had significantly higher Health ABC scores
  • 27. Discussion 27  Increased ventricular ectopy counts and abnormal HRV measures from 24-h Holter recordings, including decreased DFA1, decreased CV%, increased ln VLF, and abnormal HRT onset, added to the predictive power of the Health ABC score to identify asymptomatic older adults who are at increased risk of developing CHF  The model C-statistic increased from 0.73 to 0.77 when HRV was included.  Low-risk subcohort, as defined by NT-proBNP #190 pg/ml, the Health ABC components significantly associated with CHF were unchanged, and decreased DFA1 remained independently associated with incident CHF
  • 28. Result 28  HRV parameters were associated with incident CHF independent of the Health ABC score components  Older adults who have cardiac autonomic dysfunction, as manifested by abnormal HRV, may be predisposed to the development of CHF  DFA1, first described by Peng et al, measures the randomness of the N-N intervals (i.e., the intervals between normal heart beats in a time series  Lower value of DFA1 reflect a more disorganized, less predictable sinus rhythm  Lower DFA1 was associated with increased mortality in patients with reduced ejection fraction after MI
  • 29. Result 29  Decreased DFA1 with increased heart failure hospitalizations  Decreased DFA1 a strong risk factor for cardiovascular death  Relationship between DFA1 and incident CHF in asymptomatic older adults  Study confirmed that an increased number of PVCs was associated with an increased risk of CHF, independent of the Health ABC score components,
  • 30. Study limitations 30  HRV can only be measured in normal sinus rhythm, which exclude those with atrial fibrillation, wandering atrial pacemaker, excessive ectopy, or an underlying paced rhythm, excluding individuals who are at the greatest risk of developing CHF  Health ABC score components were obtained 2 years before the Holter recordings in the African-American cohort, these participants may have had a different Health ABC score at the time of their 24-h Holter measurements
  • 31. Study limitations 31  we did not correct for multiple comparisons, thereby increasing the risk of type I error.  Full clinical application of these findings would require that 24-h Holter recordings be analyzed to research standards
  • 32. Conclusions 32  Abnormal HRV significantly and independently associated with incident CHF  When combined with increased PVCs, improved the predictive power of the Health ABC score  Among low-risk older adults with NTproBNP 190 pg/ml, HRV added to the clinical risk model.  Identification of asymptomatic older adults with abnormal HRV could potentially help direct targeted strategies for the primary prevention of heart failure
  • 33. Take home message 33  NPVF detection and ablation may represent important therapeutic options to prevent AF recurrence, especially in patients who require repeated procedures  Abnormal HRV significantly and independently associated with incident CHF